Targeted Rna Sequencing Market Overview:
The Targeted Rna Sequencing Market Size is USD 4,554.59 Million in 2022. It is projected to reach USD 8,684.17 Million by 2030, indicating a CAGR of 8.5% during the forecast period. Targeted RNA sequencing is a cutting-edge technology that enables researchers to selectively analyze and quantify RNA molecules of interest. By focusing on specific RNA targets, this technique offers a more cost-effective and efficient alternative to whole transcriptome sequencing.
Targeted RNA sequencing, also known as capture-based RNA sequencing or gene panel sequencing, offers a solution to these challenges. By focusing on a defined set of RNA targets, researchers can achieve high sequencing depth and sensitivity while reducing costs and data complexity.
Sample Request Here: https://www.consegicbusinessintelligence.com/request-sample/1016
The need for personalized medicine and diagnostics is pushing the demand for RNA sequencing technologies. The surge in funding for genomics research and collaborations between research institutions and pharmaceutical companies is fostering innovation. Additionally, the rapid evolution of next-generation sequencing (NGS) techniques and the advent of single-cell RNA sequencing are driving market growth by enhancing accuracy and reducing costs.
Key Players in the Targeted RNA Sequencing Market
Several companies are actively involved in the targeted RNA sequencing development and commercialization of targeted RNA sequencing technologies and solutions. Some key players in the market include:
- Thermo Fisher Scientific
- Roche Holdings
- Illumina Inc.
- Oxford Nanopore Technologies
- Agilent Technologies
- DNASTAR Inc.
- Bio-Rad Laboratories Inc.
- Exome Sequencing
- Enrichment Sequencing
- Amplicon Sequencing
- Biomedical Research
- Plant & Animal Sciences
- Drug Discovery
By End User
- Academic Research
- Hospitals & Clinics
- Pharma & Biotech Entities
Click Here To Get: Targeted RNA Sequencing Market Report
The targeted RNA sequencing market in North America is driven by a robust research infrastructure, significant investments in genomics research, and the presence of major pharmaceutical and biotechnology companies. European countries have a strong emphasis on genomics research and personalized medicine, contributing to the growth of the targeted RNA sequencing market in the region. Also, The Asia Pacific region is witnessing significant growth in targeted RNA sequencing due to increasing research activities, rising investments in genomics research, and a growing focus on personalized medicine.
Contact no: (US) (505) 715-4344